Henry Schein, Inc.
A global distributor supplying office-based dentists and doctors with everything from dental implants and biomaterials to practice-management software and everyday supplies. It grew out of a single New York City pharmacy that founder Henry Schein and his wife Esther opened in 1932 during the Great Depression, later shifting to mail-order medical supplies. In those hard years, Henry kept a notebook behind the counter listing customers who couldn't pay, letting them take medicine on trust—a habit of service that shaped the company's culture.
Granted 2.6K · Sold 43.8K
Granted 60.6K
Granted 27.1K
Granted 27.1K · Sold 5.9K
Granted 95.2K
Granted 20.3K
Granted 53.2K · Sold 1.4K
Granted 2.6K
Granted 2.6K
Granted 4.8K · Bought 10.0K
Granted 2.6K · Sold 2.8K
Granted 2.6K
Granted 7.1K
Granted 2.6K
Granted 2.6K · Sold 2.8K
Granted 2.6K
Granted 2.6K
Granted 2.6K
Granted 2.6K
Granted 2.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bergman Stanley MFormer Director · 9 transactions | +28.6% | 1.31M | 2.6K | — | 43.8K |
| Albertini AndreaCEO, Global Dist. & Tech. · 2 transactions | +95% | 120.7K | 60.6K | — | — |
| Ettinger Michael SEVP & Chief Operating Officer · 4 transactions | +21.2% | 112.4K | 27.1K | — | — |
| Mlotek Mark EEVP, Chief Strategic Officer · 7 transactions | +13.9% | 109.9K | 27.1K | — | 5.9K |
| Lowery Frederick M.CEO, Director · 2 transactions | — | 95.2K | 95.2K | — | — |
| South Ronald N.SVP & Chief Financial Officer · 2 transactions | +19.3% | 88.9K | 20.3K | — | — |
| Popeck Thomas CCEO, Henry Schein Products · 3 transactions | +145.8% | 86.2K | 53.2K | — | 1.4K |
| Sheares Bradley TDirector · 1 transaction | +5.7% | 47.6K | 2.6K | — | — |
| Herring Joseph LDirector · 1 transaction | +9.3% | 30.3K | 2.6K | — | — |
| Daniel William KDirector · 3 transactions | +115.1% | 27.6K | 4.8K | 10.0K | — |
| Laskawy Philip ADirector · 2 transactions | -1.1% | 24.5K | 2.6K | — | 2.8K |
| Margulies Anne H.Director · 1 transaction | +12.5% | 23.2K | 2.6K | — | — |
| Sheehy Christine ZayacSVP, Chief Human Res. Officer · 2 transactions | +56% | 18.5K | 7.1K | — | — |
| Derby DeborahDirector · 1 transaction | +19.4% | 15.9K | 2.6K | — | — |
| Kuehn Kurt PDirector · 2 transactions | -1.7% | 15.4K | 2.6K | — | 2.8K |
| Ali MohamadDirector · 1 transaction | +20.6% | 15.1K | 2.6K | — | — |
| Tuckson Reed VaughnDirector · 1 transaction | +25.9% | 12.5K | 2.6K | — | — |
| Serota Scott PhilipDirector · 1 transaction | +85.1% | 11.8K | 2.6K | — | — |
| Faig Carole TDirector · 1 transaction | +47.3% | 8.0K | 2.6K | — | — |
| Hombach Robert J.Director · 1 transaction | +90.6% | 5.4K | 2.6K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -46.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.